Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zahra Shahrokh is active.

Publication


Featured researches published by Zahra Shahrokh.


Molecular Pharmaceutics | 2011

Erythropoietin produced in a human cell line (Dynepo) has significant differences in glycosylation compared with erythropoietins produced in CHO cell lines.

Zahra Shahrokh; Louise Royle; Radka Saldova; Jonathan Bones; Jodie L. Abrahams; Natalia V. Artemenko; Steve Flatman; Mike Davies; Alison Baycroft; Surinder Sehgal; Michael Heartlein; David J. Harvey; Pauline M. Rudd

Recombinant human erythropoietin has been used to treat anemia associated with chronic renal disease. This paper provides a comprehensive comparative analysis of Dynepo and three other commercial erythropoiesis stimulating agents, Eprex, NeoRecormon and Aranesp. We found significant differences in the type, levels and amount of O-acetylation of sialic acids. Sialic acids and O-acetylation present provide protection from clearance from circulation. Aranesp had up to six O-acetyl groups attached to the sialic acids. Eprex and NeoRecormon had only minor amounts of O-acetylation while Dynepo had none. Dynepo had no Neu5Gc, which is potentially immunogenic for humans. Dynepo contained the least amount of disialylated and Aranesp the highest amount of tetrasialylated glycans. NeoRecormon and Eprex contained more trisialylated, but less tetrasialylated glycans than Dynepo and Aranesp. Dynepo had the highest amount of tetraantennary glycans and the lowest amounts of triantennary glycans with a β1-6-GlcNAc linkage. All the samples contained poly-N-acetyl-lactosamine repeats with Dynepo having the least. The major N-acetyl-lactosamine extensions in Dynepo and Aranesp were on biantennary glycans, whereas in NeoRecomon and Eprex they were on triantennary glycans. The sLe(x) epitope was only detected in Dynepo.


Journal of Chromatography A | 2008

Peptide mapping with liquid chromatography using a basic mobile phase.

Hongji Liu; Bi Xu; Manas K. Ray; Zahra Shahrokh

A new peptide mapping with liquid chromatography (LC) using an ammonia-containing basic mobile phase was reported. As compared with a method under a traditional acidic condition with a mobile phase containing trifluoroacetic acid (TFA) or formic acid (FA), the new method exhibited excellent overall performance: it was advantageous over the TFA method in terms of the ultraviolet (UV) and mass spectrometry (MS) sensitivities and the sequence coverage for a tryptic map; it was superior to the FA method in terms of the UV sensitivity, the sequence coverage and the separation capacity. Due to a significant difference in the chromatographic selectivity, several important peptide mapping applications that were sometimes difficult to be conducted previously could now be carried out using the new method. For example, the baseline separation of peptides from the corresponding deamidated products could be achieved with confidence using the new method, a critical pre-requisite for definitive identification and quantification of the deamidation products with LC/MS. No on-column deamidation was observed with the conditions used for the separation. Complementary and confirmative information about a protein could be obtained by running its proteolytic digest under both the basic and acidic conditions.


Archive | 2011

Methods and compositions for CNS delivery of iduronate-2-sulfatase

Gaozhong Zhu; Kris Lowe; Zahra Shahrokh; James Christian; Rick Richard Fahmer; Jing Pan; Teresa Leah Wright; Pericles Calias


Archive | 2011

Cns delivery of therapeutic agents

Pericles Calias; Jing Pan; Jan Powell; Lawrence Charnas; Thomas McCauley; Teresa Leah Wright; Richard Pfeifer; Zahra Shahrokh


Archive | 2007

Stabilized compositions of proteins having a free thiol moiety

Gaozhong Zhu; Vinh Nguyen; Kris Lowe; Zahra Shahrokh


Archive | 2011

Methods and compositions for cns delivery of heparan n-sulfatase

Farah Natoli; Gaozhong Zhu; Jennifer Terew; Yuan Jiang; Jamie Tsung; Zahra Shahrokh; Brian Vernaglia; Jing Pan; Richard Pfeifer; Pericles Calias


Archive | 2011

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF β-GALACTOCEREBROSIDASE

Nazila Salamat-Miller; Katherine Taylor; Ken Manning; Gaozhong Zhu; Zahra Shahrokh; Pericles Calias; Thomas McCauley


Archive | 2011

Methods and compositions for CNS delivery of arylsulfatase A

Nazila Salamat-Miller; Katherine Taylor; Zahra Shahrokh; Jing Pan; Lawrence Charnas; Teresa Leah Wright; Pericles Calias


Archive | 2008

SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALACTOSIDASE A

Lisa Marie Sturk; Justin C. Lamsa; Michael Heartlein; Vinh Nguyen; Katherine Taylor; Zahra Shahrokh


Archive | 2012

Stable formulations for cns delivery of arylsulfatase a

Nazila Salamat-Miller; Katherine Taylor; Zahra Shahrokh; Jing Pan; Lawrence Charnas; Teresa Leah Wright; Pericles Calias; Keethkumar Jain; Sujit K. Basu

Collaboration


Dive into the Zahra Shahrokh's collaboration.

Top Co-Authors

Avatar

Jonathan Bones

University College Dublin

View shared research outputs
Top Co-Authors

Avatar

Louise Royle

University College Dublin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge